Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic Warms To Cryoablation With $380 Million Acquisition Of CryoCath

This article was originally published in The Gray Sheet

Executive Summary

Medtronic gains a stake in the race to get the first FDA approval of an ablation catheter for atrial fibrillation with its $380 million acquisition of Montreal-based CryoCath, announced Sept. 25
Advertisement

Related Content

Medtronic’s Hawkins To Retire; Company Sets External Search For New CEO
Medtronic’s Hawkins To Retire; Company Sets External Search For New CEO
Medtronic STOP AF Results Show Efficacy, But Raise Some Safety Concerns
Medtronic STOP AF Results Show Efficacy, But Raise Some Safety Concerns
ACC 2010: Transcatheter Mitral Valve Repair Data Among Expected Highlights
Research In Brief
AngioDynamics Taps Former CryoCath Chief Keltjens For CEO Slot
Medtronic Makes Another Big Play In A-Fib, Purchases Ablation Frontiers
J&J Gets Panel Date Seeking First A-Fib Ablation Catheter Indication
Boston Scientific buys CryoCor
Advertisement
UsernamePublicRestriction

Register

MT026621

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel